Cargando…

Immune infiltration in aggressive papillary craniopharyngioma: High infiltration but low action

Papillary craniopharyngiomas (PCPs) are biologically benign but clinically aggressive lesions hence affect the quality of life. The expression of inflammatory mediators and regulation of the immune microenvironment in PCPs have not been investigated much. In this study, for the first time, we assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Yanfei, Ma, Lin, Cai, Kefan, Zhang, Bochao, Wu, Wentao, Xiao, Youchao, Qiao, Ning, Ru, Siming, Cao, Lei, Gao, Hua, Gui, Songbai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664078/
https://www.ncbi.nlm.nih.gov/pubmed/36389809
http://dx.doi.org/10.3389/fimmu.2022.995655
_version_ 1784831025149378560
author Jia, Yanfei
Ma, Lin
Cai, Kefan
Zhang, Bochao
Wu, Wentao
Xiao, Youchao
Qiao, Ning
Ru, Siming
Cao, Lei
Gao, Hua
Gui, Songbai
author_facet Jia, Yanfei
Ma, Lin
Cai, Kefan
Zhang, Bochao
Wu, Wentao
Xiao, Youchao
Qiao, Ning
Ru, Siming
Cao, Lei
Gao, Hua
Gui, Songbai
author_sort Jia, Yanfei
collection PubMed
description Papillary craniopharyngiomas (PCPs) are biologically benign but clinically aggressive lesions hence affect the quality of life. The expression of inflammatory mediators and regulation of the immune microenvironment in PCPs have not been investigated much. In this study, for the first time, we assessed the immune cell infiltration and immune cell signatures in PCPs by analyzing the bulk-RNA sequencing data and immunohistochemical staining. Additionally, we performed qRT-PCR analysis to detect inflammatory mediators interleukin-1α (IL1A) and interleukin-6 (IL6) in different aggressive groups and then developed the IL1A and IL6 prediction models for defining the degree of hypothalamic invasion. Lastly, we defined differentially expressed genes related to invasiveness and implemented enrichment analysis to them. Our results indicated that PCPs are in a state of high immune infiltration but low action with abundant inflammatory cells. High infiltration of neutrophils may lead a low active immune microenvironment. Furthermore, the high expression level of IL1A and IL6 was positively correlated with the invasion of PCP tumors in the hypothalamus. These findings provide new pathological insights into the underlying mechanism of the immune microenvironment in PCP tumors. Moreover, IL1A and IL6 might serve as potential therapeutic targets for PCP tumors, especially to prevent their invasion into the hypothalamus.
format Online
Article
Text
id pubmed-9664078
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96640782022-11-15 Immune infiltration in aggressive papillary craniopharyngioma: High infiltration but low action Jia, Yanfei Ma, Lin Cai, Kefan Zhang, Bochao Wu, Wentao Xiao, Youchao Qiao, Ning Ru, Siming Cao, Lei Gao, Hua Gui, Songbai Front Immunol Immunology Papillary craniopharyngiomas (PCPs) are biologically benign but clinically aggressive lesions hence affect the quality of life. The expression of inflammatory mediators and regulation of the immune microenvironment in PCPs have not been investigated much. In this study, for the first time, we assessed the immune cell infiltration and immune cell signatures in PCPs by analyzing the bulk-RNA sequencing data and immunohistochemical staining. Additionally, we performed qRT-PCR analysis to detect inflammatory mediators interleukin-1α (IL1A) and interleukin-6 (IL6) in different aggressive groups and then developed the IL1A and IL6 prediction models for defining the degree of hypothalamic invasion. Lastly, we defined differentially expressed genes related to invasiveness and implemented enrichment analysis to them. Our results indicated that PCPs are in a state of high immune infiltration but low action with abundant inflammatory cells. High infiltration of neutrophils may lead a low active immune microenvironment. Furthermore, the high expression level of IL1A and IL6 was positively correlated with the invasion of PCP tumors in the hypothalamus. These findings provide new pathological insights into the underlying mechanism of the immune microenvironment in PCP tumors. Moreover, IL1A and IL6 might serve as potential therapeutic targets for PCP tumors, especially to prevent their invasion into the hypothalamus. Frontiers Media S.A. 2022-11-01 /pmc/articles/PMC9664078/ /pubmed/36389809 http://dx.doi.org/10.3389/fimmu.2022.995655 Text en Copyright © 2022 Jia, Ma, Cai, Zhang, Wu, Xiao, Qiao, Ru, Cao, Gao and Gui https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Jia, Yanfei
Ma, Lin
Cai, Kefan
Zhang, Bochao
Wu, Wentao
Xiao, Youchao
Qiao, Ning
Ru, Siming
Cao, Lei
Gao, Hua
Gui, Songbai
Immune infiltration in aggressive papillary craniopharyngioma: High infiltration but low action
title Immune infiltration in aggressive papillary craniopharyngioma: High infiltration but low action
title_full Immune infiltration in aggressive papillary craniopharyngioma: High infiltration but low action
title_fullStr Immune infiltration in aggressive papillary craniopharyngioma: High infiltration but low action
title_full_unstemmed Immune infiltration in aggressive papillary craniopharyngioma: High infiltration but low action
title_short Immune infiltration in aggressive papillary craniopharyngioma: High infiltration but low action
title_sort immune infiltration in aggressive papillary craniopharyngioma: high infiltration but low action
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664078/
https://www.ncbi.nlm.nih.gov/pubmed/36389809
http://dx.doi.org/10.3389/fimmu.2022.995655
work_keys_str_mv AT jiayanfei immuneinfiltrationinaggressivepapillarycraniopharyngiomahighinfiltrationbutlowaction
AT malin immuneinfiltrationinaggressivepapillarycraniopharyngiomahighinfiltrationbutlowaction
AT caikefan immuneinfiltrationinaggressivepapillarycraniopharyngiomahighinfiltrationbutlowaction
AT zhangbochao immuneinfiltrationinaggressivepapillarycraniopharyngiomahighinfiltrationbutlowaction
AT wuwentao immuneinfiltrationinaggressivepapillarycraniopharyngiomahighinfiltrationbutlowaction
AT xiaoyouchao immuneinfiltrationinaggressivepapillarycraniopharyngiomahighinfiltrationbutlowaction
AT qiaoning immuneinfiltrationinaggressivepapillarycraniopharyngiomahighinfiltrationbutlowaction
AT rusiming immuneinfiltrationinaggressivepapillarycraniopharyngiomahighinfiltrationbutlowaction
AT caolei immuneinfiltrationinaggressivepapillarycraniopharyngiomahighinfiltrationbutlowaction
AT gaohua immuneinfiltrationinaggressivepapillarycraniopharyngiomahighinfiltrationbutlowaction
AT guisongbai immuneinfiltrationinaggressivepapillarycraniopharyngiomahighinfiltrationbutlowaction